JNHMF (Jack Nathan Medical) NonCurrent Deferred Revenue: $0.45 Mil (As of Oct. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Jack Nathan Medical NonCurrent Deferred Revenue?

Jack Nathan Medical JNHMF -90.42% NonCurrent Deferred Revenue is $0.45 Mil as of Oct. 2023.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

Jack Nathan Medical's non-current deferred revenue for the quarter that ended in Oct. 2023 was $0.45 Mil.

Jack Nathan Medical NonCurrent Deferred Revenue Related Terms

Jack Nathan Medical NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Jack Nathan Medical's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jack Nathan Medical NonCurrent Deferred Revenue Chart

Jack Nathan Medical Annual Data
Trend Dec18 Dec19 Jan20 Jan21 Jan22 Jan23
NonCurrent Deferred Revenue
Get a 7-Day Free Trial 0.00 0.40 0.43 0.50 0.00

Jack Nathan Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.00 0.00 0.45 0.45
What does a NonCurrent Deferred Revenue of $0.45 Mil mean?
Jack Nathan Medical (JNHMF) has a NonCurrent Deferred Revenue of $0.45 Mil as of Oct. 2023. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Jack Nathan Medical and its competitors.
Is Jack Nathan Medical's NonCurrent Deferred Revenue too high?
Jack Nathan Medical's current NonCurrent Deferred Revenue is $0.45 Mil.
How does Jack Nathan Medical's NonCurrent Deferred Revenue compare to HCA and UHS?
Jack Nathan Medical's NonCurrent Deferred Revenue of $0.45 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Healthcare Providers & Services company?
A good NonCurrent Deferred Revenue depends on the Healthcare Providers & Services industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Jack Nathan Medical and its competitors. Jack Nathan Medical's current NonCurrent Deferred Revenue is $0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jack Nathan Medical stock overvalued right now?
Jack Nathan Medical (JNHMF) has a current NonCurrent Deferred Revenue of $0.45 Mil. The current NonCurrent Deferred Revenue is $0.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For Jack Nathan Medical (JNHMF), the current NonCurrent Deferred Revenue is $0.45 Mil as of Oct. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jack Nathan Medical Business Description

Address 6 - 6150 Highway 7, Suite 491, Jack Nathan Health, Woodbridge, ON, CAN, L4H 0R6
Jack Nathan Medical Corp is a provider of primary care medical clinics located in Walmart Supercentres under the Jack Nathan Health brand. The company designs, builds and sets barrier-free medical clinics for physicians in high-density centers, providing patients with an opportunity to receive immediate access to quality care in modern facilities.